These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31172218)

  • 21. Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.
    Berry E; Bosonea AM; Wang X; Fernandez-Patron C
    J Vasc Res; 2013; 50(1):52-68. PubMed ID: 23172306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metalloproteinases in melanoma.
    Moro N; Mauch C; Zigrino P
    Eur J Cell Biol; 2014; 93(1-2):23-9. PubMed ID: 24530009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
    Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma.
    Rooprai HK; Martin AJ; King A; Appadu UD; Jones H; Selway RP; Gullan RW; Pilkington GJ
    Int J Oncol; 2016 Dec; 49(6):2309-2318. PubMed ID: 27779709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key metalloproteinase-mediated pathways in the kidney.
    Wozniak J; Floege J; Ostendorf T; Ludwig A
    Nat Rev Nephrol; 2021 Aug; 17(8):513-527. PubMed ID: 33879883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia.
    Nuttall RK; Silva C; Hader W; Bar-Or A; Patel KD; Edwards DR; Yong VW
    Glia; 2007 Apr; 55(5):516-26. PubMed ID: 17216595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases and neuroinflammation in multiple sclerosis.
    Rosenberg GA
    Neuroscientist; 2002 Dec; 8(6):586-95. PubMed ID: 12467380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of matrix metalloproteinases.
    Mandal M; Mandal A; Das S; Chakraborti T; Sajal C
    Mol Cell Biochem; 2003 Oct; 252(1-2):305-29. PubMed ID: 14577606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
    Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
    J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular metalloproteinases in neural crest development and craniofacial morphogenesis.
    Christian L; Bahudhanapati H; Wei S
    Crit Rev Biochem Mol Biol; 2013; 48(6):544-60. PubMed ID: 24066766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Matrix metalloproteinases in the central nervous system: clinical significance and therapeutic prospects].
    Sulik A; Ołdak E
    Pol Merkur Lekarski; 2008 Mar; 24(141):278-80. PubMed ID: 18634301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
    Rivera S; García-González L; Khrestchatisky M; Baranger K
    Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of ADAM and ADAMTS metalloproteinases in airway diseases.
    Paulissen G; Rocks N; Gueders MM; Crahay C; Quesada-Calvo F; Bekaert S; Hacha J; El Hour M; Foidart JM; Noel A; Cataldo DD
    Respir Res; 2009 Dec; 10(1):127. PubMed ID: 20034386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
    Hida Y; Hamada J
    Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.
    Pasternak B; Aspenberg P
    Acta Orthop; 2009 Dec; 80(6):693-703. PubMed ID: 19968600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.